Background: Improving treatment outcomes for younger Black MSM (YBMSM) is critical to controlling the HIV epidemic domestically. A seminal meta-analysis conducted by Millet in 2012 reviewed factors associated with increased rates of HIV among Black MSM and highlighted several disparities compared to white MSM. We examine how these disparate factors are related to HIV treatment continuum metrics from the first population-based sample of YBMSM 16-29 years of age.
Methods: From 2013-2014 a representative sample of YBMSM was generated using Respondent Driven Sampling (RDS) in Chicago (n=626). HIV antibody/Ag and RNA testing were performed using dry blood spots. Outcomes were computed for steps in the treatment continuum including HIV tested, HIV diagnosed, linkage to care within 6 months, retained in care (2 or more visits 3 months apart in 1 year), 30 day adherence to ARVs, and laboratory confirmed viral suppression. RDS-unweighted models examined the associations between key factors known to disparately impact BMSM and each of the continuum metrics independently with observations inclusive of participants unique to each step. These models included age, education, unemployment, homelessness, health care coverage, drug use, incarceration and depression.
Results: YBMSM had a 28% seropositivity rate; 31% of positives were virally suppressed. Treatment continuum outcomes are in Figure 1. Factors associated with HIV diagnosis included older (aOR, 1.12; p=0.001), insured (aOR, 2.31; p=0.001), and drug using (aOR, 1.86; p=0.01) YBMSM. Factors associated with linkage to care included unemployment (aOR, 6.76; p=0.04) and insured status (aOR, 4.24; p=0.04). Those who used drugs were both less likely to be prescribed ARVs (aOR, 0.003; p=0.024) and less likely to adhere to ARVs (aOR, 0.29, p=0.046). There were no factors associated with retention in care or viral suppression.
Conclusions: Treatment continuum metrics among YBMSM are similar to the general HIV infected population. Several structural factors are associated with these metrics such as drug use; some like unemployment may have opposite than anticipated relationships. Notably, metrics such as retention in care and viral suppression are not associated with key structural factors that disproportionately affect YBMSM such as homelessness and incarceration. More research is needed to determine and intervene upon key drivers related to HIV treatment continuum metrics among YBMSM, with particular attention to the diversity of drivers related to each step.
Treatment Continuum for a population-based sample of younger Black men who have sex with men ages 16-29 in Chicago (n=626).